Provided by Tiger Trade Technology Pte. Ltd.

Psyence Biomedical Ltd

4.34
+0.13003.09%
Post-market: 4.28-0.0600-1.38%18:50 EDT
Volume:26.54K
Turnover:112.62K
Market Cap:16.55M
PE:-0.35
High:4.40
Open:4.22
Low:4.10
Close:4.21
52wk High:34.63
52wk Low:1.92
Shares:3.81M
Float Shares:1.09M
Volume Ratio:0.83
T/O Rate:2.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.5596
EPS(LYR):-12.5596
ROE:-58.62%
ROA:-31.33%
PB:0.98
PE(LYR):-0.35

Loading ...

Nov 07, 2024

Correspondence

Form CORRESP - Correspondence
Oct 30, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Oct 08, 2024

Correspondence

Form CORRESP - Correspondence
Oct 02, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Aug 27, 2024

Correspondence

Form CORRESP - Correspondence
Aug 20, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Jul 31, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 27, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
May 13, 2024

Correspondence

Form CORRESP - Correspondence
May 10, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
May 09, 2024

Correspondence

Form CORRESP - Correspondence
May 07, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
May 06, 2024

Correspondence

Form CORRESP - Correspondence
Apr 18, 2024

Correspondence

Form CORRESP - Correspondence
Apr 18, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Feb 10, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Feb 05, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jan 31, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Jan 23, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations